| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-26 | FY 2024
FILED 2024-12-27 | FY 2023
FILED 2023-12-29 |
|---|---|---|---|
| Revenue (Total Sales) | $947.7M | $849.0M | $811.1M |
| YoY Revenue Growth % | +11.6% | +4.7% | — |
| Gross Profit | $87.8M | $103.3M | — |
| Gross Margin % | 9.3% | 12.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$39.3M | -$7.6M | -$10.9M |
| Operating Margin % | -4.1% | -0.9% | -1.3% |
| Net Income (GAAP) | -$52.8M | -$20.8M | -$43.0M |
| EBITDA (Normalized) | -$10.3M | $6.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $29.9M | $27.9M | $57.6M |
| Capital Expenditures (CapEx) | $36.2M | $17.6M | — |
| Free Cash Flow (FCF) | -$6.3M | $10.2M | $57.6M |
| FCF Margin % | -0.7% | 1.2% | 7.1% |
| Return on Invested Capital (ROIC %) | -4.5% | -0.8% | — |
| Cash & Short-Term Equivalents | $98.3M | $108.7M | — |
| Total Debt (Short + Long Term) | $117.3M | $121.0M | — |
| Total Stockholders' Equity | $663.9M | $698.3M | — |